EARNING RECAP

Snap Inc

#SNAP 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q1 adjusted (10c) est. 12c) $320.43M est. $306.48M -6.09% ($11.26 closing prive0 $12.42 $11.06 sees Q2 revenue $335-$360M est. $348.04M; Q1 DAUs 190M compared to $186M in Q4 2018 & 191M in Q1 2018;
#SNAP 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted (13c) est. (8c) $390M est. $375.82M +22.02% ($8.59 closing price) $9.09 $8.35 sees Q1 revenue $285M-$310M est. $307.18M; adjusted EBITS between ($165M)-($140M) vs. ($218M) last year; reports Q4 DAU 186M vs. 187M last yr. vs. 186M last qtr
Q3 (12c) est. (14c) $298M est. $283.21M -10.16% ($6.28 closing price) $6.28 $5.77 sees Q4 revenue $355M- $380M est. $370.96M, assumes Q4 DAU will decline sequentially
Q2 (14c) est. (17c) $262.26M est. $251.19M -6.78% ($12.23 closing) $12.84 $12.04 Q2 DAU 188M up 8% from last year; ARPU up 34% compared to Q2 2017; sees Q3 revenue $265M -$290M est. $290.1M
Q1 (17C) Vs (17c) $230.67M vs $243.55M -21.94% ($11.03 closing) $11.70 $10.96 Q1 DAU 191M
#SNAP 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 (13c) est (16c) $285.7M est. $252.95M +47.58% ( $20.75 closing) $21.22 $16.70 Q4 DAU's up 10% YoY, up 5% from last quarter
Q3 (14c) est. (15c) $207.94M est. $239.5M -14.62% ($12.91 closing) $14.09 $12.10 Revenue & DAU miss*
Q2 Adjusted (16c) vs (15c) $181.67M vs $186.22M -14.09% ($11.83 closing) $12.34 $11.77 Q2 ARPU $1.05, up 109%y/y. DAU 61c vs 55c last year. Stock -6.17% after hours. To $13.00
Q1 Q1 GAAP EPS ($2.31) vs. (14c) last year $149.65M, consensus $157.98M -21.45% ($18.05 closing) $18.90 $17.59 -25% @ $17.08. Global DAUs:166 mill vs 167.3 expected. Loss $2.31 a share

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.